In this interview with Dr. Thomas Hefti, CEO of Bottneuro, we explore how they are transforming neurocognitive care from the heart of Basel’s life sciences ecosystem.
In this interview with Dr. Simon Ittig, CEO of T3 Pharma, we explore how they moved from academia to entrepreneurship, scaled within Basel’s vibrant biotech hub, and became part of Boehringer Ingelheim’s CHF 450 million acquisition, all while shaping the next generation of cancer care.
CNS Therapy is revolutionizing the approach to chronic pain management. By developing a unique solution that combines behavioral therapy with cutting-edge medical devices, they help patients live pain-free lives.
TOSA Swisstech scales from research to clean energy production in the Canton of Jura after being incubated at Switzerland Innovation Park Basel Area in Courroux.
The collaboration between Engimmune Therapeutics and the Swiss Technology Innovation Center CSEM accelerates cancer screening. Their shared success fast-tracked by having their offices just one staircase away at the Switzerland Innovation Park Basel Area – Main Campus.